These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6800057)

  • 1. Antithrombin III levels during heparin therapy.
    Rao AK; Niewiarowski S; Guzzo J; Day HJ
    Thromb Res; 1981 Oct 1-15; 24(1-2):181-6. PubMed ID: 6800057
    [No Abstract]   [Full Text] [Related]  

  • 2. Management of venous thromboembolism.
    Lancet; 1988 Feb; 1(8580):275-7. PubMed ID: 2893086
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant therapy for venous thromboembolism.
    Raskob GE; Carter CJ; Hull RD
    Prog Hemost Thromb; 1989; 9():1-27. PubMed ID: 2643814
    [No Abstract]   [Full Text] [Related]  

  • 4. Heparin-induced decrease in circulating antithrombin-III.
    Marciniak E; Gockerman JP
    Lancet; 1977 Sep; 2(8038):581-4. PubMed ID: 71399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of heparin and oral anticoagulants to prevent and treat deep venous thrombosis and pulmonary embolism].
    Hamerschlak N; Rosenfeld LG
    Arq Bras Cardiol; 1996 Sep; 67(3):209-13. PubMed ID: 9181717
    [No Abstract]   [Full Text] [Related]  

  • 6. Heparin in the treatment of venous thrombo-embolic disease: administration, control and results.
    O'Sullivan EF; Hirsh J; McCarthy RA; de Gruchy GC
    Med J Aust; 1968 Jul; 2(4):153-9. PubMed ID: 5670883
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparative study on heparin and a synthetic thrombin inhibitor no. 805 (MD-805*) in experimental antithrombin III-deficient animals.
    Kumada T; Abiko Y
    Thromb Res; 1981 Nov; 24(4):285-98. PubMed ID: 6977887
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapy for pulmonary embolism.
    Sasahara AA
    JAMA; 1974 Sep; 229(13):1795-8. PubMed ID: 4479314
    [No Abstract]   [Full Text] [Related]  

  • 9. Antithrombin III and heparin.
    Kakkar VV; Bentley PG; Scully MF; MacGregor IR; Jones NA; Webb PJ
    Lancet; 1980 Jan; 1(8159):103-4. PubMed ID: 6101409
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of anticoagulant treatment measured by fibrinopeptide A (fpA) in patients with venous thrombo-embolism.
    Peuscher FW; van Aken WG; Flier OT; Stoepman-van Dalen EA; Cremer-Goote TM; van Mourik JA
    Thromb Res; 1980 Apr 1-15; 18(1-2):33-43. PubMed ID: 7404504
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of the subcutaneous heparin pump during pregnancy.
    Barss VA; Schwartz PA; Greene MF; Phillippe M; Saltzman D; Frigoletto FD
    J Reprod Med; 1985 Dec; 30(12):899-901. PubMed ID: 4078826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anticoagulant therapy for deep vein thrombosis: its proper application.
    Rohrer MJ; Anderson FA
    Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021
    [No Abstract]   [Full Text] [Related]  

  • 13. Current concepts: the use of heparin.
    Deykin D
    N Engl J Med; 1969 Apr; 280(17):937-8. PubMed ID: 5775632
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis and conservative management of venous thrombosis and pulmonary embolism.
    Hunt PS
    Ulster Med J; 1969; 38(1):76-87. PubMed ID: 5804358
    [No Abstract]   [Full Text] [Related]  

  • 15. [Plasma antithrombin III activity in patients with pulmonary thromboembolism].
    Vertun B; Filipecki S; Szczepański M; Wawrzyńska L; Rózycka J
    Pol Tyg Lek; 1992 Aug 18-31; 47(34-35):726-9. PubMed ID: 1488357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anticoagulants in venous thromboembolism. Prophylactic and therapeutic use.
    Hirsh J; Gallus AS
    Postgrad Med; 1974 Jan; 55(1):211-7. PubMed ID: 4588719
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of venous thromboembolic disease.
    Gallus AS; Hirsh J
    Semin Thromb Hemost; 1976 Apr; 2(4):291-331. PubMed ID: 798277
    [No Abstract]   [Full Text] [Related]  

  • 18. Heparin therapy.
    Raich PC; Hahn MF; Korst DR
    Am Fam Physician; 1974 Sep; 10(3):163-8. PubMed ID: 4413661
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of heparin fractions: some overlooked considerations.
    Fareed J
    Semin Thromb Hemost; 1985 Apr; 11(2):227-36. PubMed ID: 3898374
    [No Abstract]   [Full Text] [Related]  

  • 20. Management of venous thromboembolism.
    Ginsberg JS
    N Engl J Med; 1996 Dec; 335(24):1816-28. PubMed ID: 8943165
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.